Evofem Biosciences, Inc.
EVFM- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001618835
No open-market purchases or sales by Evofem Biosciences, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Evofem Biosciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 8 | 0 | −8 |
| Shares | 46.4K | 0 | −46.4K (−100.0%) |
| Value | $122.0K | $0 | −$122.0K (−100.0%) |
New holders (0)
Institutions that held Evofem Biosciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
None.
Sold out (8)
Institutions that held Evofem Biosciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Westside Investment Management, Inc. | 666 | $113.0K |
| Clear Street LLC | 30,000 | $5.00K |
| IFP Advisors, Inc | 30 | $2.00K |
| Activest Wealth Management | 14,667 | $2.00K |
| Laffer Tengler Investments | 15 | $2 |
| Barclays PLC | 433 | $0 |
| Creative Financial Designs Inc | 20 | $0 |
| Simplex Trading, LLC | 546 | $0 |